Does ENASIDENIB Cause Lymphadenopathy? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Lymphadenopathy have been filed in association with ENASIDENIB (Idhifa). This represents 0.1% of all adverse event reports for ENASIDENIB.
5
Reports of Lymphadenopathy with ENASIDENIB
0.1%
of all ENASIDENIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Lymphadenopathy From ENASIDENIB?
Of the 5 reports, 4 (80.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Lymphadenopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
What Other Drugs Cause Lymphadenopathy?
ADALIMUMAB (1,637)
RITUXIMAB (1,209)
METHOTREXATE (962)
PREDNISONE (958)
CYCLOPHOSPHAMIDE (941)
IBRUTINIB (929)
ETANERCEPT (802)
DUPILUMAB (760)
DOXORUBICIN (705)
VINCRISTINE (649)
Which ENASIDENIB Alternatives Have Lower Lymphadenopathy Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ